Sidley Austin represented OMERS Life Sciences in the transaction, while Latham & Watkins advised Verona Pharma and Sullivan & Cromwell represented Oaktree Capital Management, L.P. Verona...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here